发明名称 |
NOVEL PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (2) |
摘要 |
<p>A compound of the following general formula or its salt or a hydrate thereof exhibits excellent hepatocyte growth factor receptor (HGFR) inhibiting activity and provides a compound having antitumor activity, vascularization inhibiting activity or cancer metastasis inhibiting activity or its salt or a hydrate thereof. (wherein R<1> represents a C1-C6 alkyl, etc.; each of R<2> and R<3> represents a hydrogen atom; R<4>, R<5>, R<6> and R<7> may be identical with or different from each other and each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl, etc.; R<8> represents a hydrogen atom, etc.; R<9b> represents a 3 to 10-membered nonaromatic heterocyclic group, etc.; V<1> represents an oxygen atom, etc.; V<2> represents an oxygen atom or a sulfur atom; W represents a group of the formula -CH2-, etc.; X represents a group of the formula -CH=, a nitrogen atom, etc.; and Y represents an oxygen atom, etc.).</p> |
申请公布号 |
WO2005082855(A1) |
申请公布日期 |
2005.09.09 |
申请号 |
WO2005JP03704 |
申请日期 |
2005.02.25 |
申请人 |
EISAI CO., LTD.;MATSUSHIMA, TOMOHIRO;TAKAHASHI, KEIKO;FUNASAKA, SETSUO;OBAISHI, HIROSHI |
发明人 |
MATSUSHIMA, TOMOHIRO;TAKAHASHI, KEIKO;FUNASAKA, SETSUO;OBAISHI, HIROSHI |
分类号 |
A61K31/44;A61K31/4409;A61K31/4427;A61K31/4439;A61K31/444;A61K31/4545;A61K31/496;A61K31/505;A61K31/506;A61K31/5377;A61K31/551;A61P1/18;A61P9/00;A61P11/00;A61P13/08;A61P13/12;A61P15/00;A61P25/00;A61P35/00;A61P35/04;A61P43/00;C07D213/73;C07D213/75;C07D239/46;C07D239/47;C07D239/48;C07D401/12;C07D401/14;C07D403/12;C07D407/12;C07D409/12;C07D413/12;C07D487/08;(IPC1-7):C07D213/75;A61K31/537;A61K31/442 |
主分类号 |
A61K31/44 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|